PDCD1 and neoplasm: found that triple therapy with anti-CTLA-4 antibody, anti-PD-1 antibody, and an oncolytic adenovirus downregulated the expression of tumor growth-related genes, upregulated perforin and granzyme expression, and suppressed liver and lung metastasis of breast tumors.